Previously treated cases tested for RR-/MDR-TB in Belgium
Belgium: Previously treated cases tested for RR-/MDR-TB was 83.0% in 2024. ▲ Rising
Previously treated cases tested for RR-/MDR-TB in Belgium, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for previously treated cases tested for rr-/mdr-tb in Belgium is 83.0%, measured in 2024.
That represents a change of down 16.2% on the previous year and up 13.7% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Belgium peaked at 99.0% in 2023 and was at its lowest, 59.0%, in 2011.
That places Belgium 104th out of 180 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 20 years of available data.
Previously treated cases tested for RR-/MDR-TB in Belgium, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 60.0% | — |
| 2006 | 68.0% | +13.3% |
| 2007 | 71.0% | +4.4% |
| 2008 | 72.0% | +1.4% |
| 2009 | 70.0% | -2.8% |
| 2010 | 69.0% | -1.4% |
| 2011 | 59.0% | -14.5% |
| 2012 | 68.0% | +15.3% |
| 2013 | 64.0% | -5.9% |
| 2014 | 73.0% | +14.1% |
| 2015 | 70.0% | -4.1% |
| 2016 | 72.0% | +2.9% |
| 2017 | 77.0% | +6.9% |
| 2018 | 74.0% | -3.9% |
| 2019 | 75.0% | +1.4% |
| 2020 | 71.0% | -5.3% |
| 2021 | 71.0% | +0.0% |
| 2022 | 73.0% | +2.8% |
| 2023 | 99.0% | +35.6% |
| 2024 | 83.0% | -16.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 68.2% | 60.0% | 72.0% | 5 |
| 2010s | 70.1% | 59.0% | 77.0% | 10 |
| 2020s | 79.4% | 71.0% | 99.0% | 5 |
Countries ranked near Belgium
More health data for Belgium
- Un projection of annual infant deaths, annual growth rate -3.28 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2923 % change on previous year (2090)
- Heat deaths vs projected death rates 1,160 (2090)
- Un projection of annual infant deaths 59 (2100)
- Population ages 65 and above, female, annual growth rate 2.35 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.1154 units per person (2025)
- Population ages 65 and above, male, annual growth rate 3.07 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.0942 units per person (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Belgium?
- Previously treated cases tested for rr-/mdr-tb in Belgium was 83.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Belgium?
- The highest recorded value was 99.0% in 2023.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Belgium?
- The lowest recorded value was 59.0% in 2011.
- How does Belgium rank for previously treated cases tested for rr-/mdr-tb?
- Belgium ranks 104th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Belgium?
- Over the last ten years it is up 13.7%. The long-run trend across the full record is rising.
- Where does this Belgium data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).